On October 13, Astera Labs, Inc. fell 5.57% in Regular Trading, trading at $304.51 per share, with turnover of $94.73 million.

The clearest disclosed catalyst is continued pressure after Northland Securities downgraded the stock to market perform from outperform, while profit-taking intensified ahead of the company’s November 3 third-quarter earnings release.

Recent market reports on the same date said the stock was already under pressure in earlier trading following that rating cut. Supporting context indicates the broader analyst view remained constructive, with an average rating of overweight or buy-equivalent and a mean target price of $416.78, while market expectations for the next quarterly EPS were about $0.83. Even so, the downgrade appears to have weighed on near-term sentiment and contributed to the latest sell-off.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)